Ilocaps
Brand names,
Ilocaps
Analogs
Ilocaps
Brand Names Mixture
Ilocaps
Chemical_Formula
C9H13NO2
Ilocaps
RX_link
No information avaliable
Ilocaps
fda sheet
Ilocaps
msds (material safety sheet)
Ilocaps
Synthesis Reference
No information avaliable
Ilocaps
Molecular Weight
167.205 g/mol
Ilocaps
Melting Point
96 oC
Ilocaps
H2O Solubility
2500 mg/L
Ilocaps
State
Solid
Ilocaps
LogP
1.514
Ilocaps
Dosage Forms
No information avaliable
Ilocaps
Indication
Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.
Ilocaps
Pharmacology
Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.
Ilocaps
Absorption
Rapidly absorbed following oral administration.
Ilocaps
side effects and Toxicity
Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.
Ilocaps
Patient Information
Ilocaps
Organisms Affected
Humans and other mammals